Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chlorpropamide-induced optic neuropathy

J Wymore, J E Carter

    Archives of Internal Medicine
    |February 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Diabetic patients experiencing vision loss may have toxic optic neuropathy caused by chlorpropamide. Discontinuing this medication can restore vision, highlighting the importance of considering drug-induced causes in diagnosis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A review of perioperative mortality in pet rabbits in Australia.

    Australian veterinary journal·2024
    Same author

    "Minimally Invasive" Skin Grafting With Enzymatic Debridement and Autologous Skin Cell Spray: A Retrospective Case Series.

    Annals of burns and fire disasters·2024
    Same author

    Demonstration of the safety and effectiveness of the RECELL<sup>®</sup> System combined with split-thickness meshed autografts for the reduction of donor skin to treat mixed-depth burn injuries.

    Burns : journal of the International Society for Burn Injuries·2018
    Same author

    Clinical safety of percutaneous ultrasound-guided fine-needle aspiration of adrenal gland lesions in 19 dogs.

    The Journal of small animal practice·2018
    Same author

    Young-onset dementia and the need for specialist care: a national and international perspective.

    Aging & mental health·2017
    Same author

    A Latent Trait Analysis of the MMPI.

    Multivariate behavioral research·2016
    Same journal

    Elevated CK-MB With Normal Total Creatine Kinase Levels in Patients Undergoing Maintenance Hemodialysis-Reply.

    Archives of internal medicine·2017
    Same journal

    Occult Carbon Monoxide Poisoning-Reply.

    Archives of internal medicine·2017
    Same journal

    Acquired Immune Deficiency Syndrome-Reply.

    Archives of internal medicine·2017
    Same journal

    Heparin Side Effects-Reply.

    Archives of internal medicine·2017
    Same journal

    Humanizing primary care medicine begins with stress.

    Archives of internal medicine·2017
    Same journal

    Legend omitted and number misrepresented.

    Archives of internal medicine·2013
    See all related articles

    Area of Science:

    • Ophthalmology
    • Endocrinology
    • Pharmacology

    Background:

    • Diabetes mellitus is a common condition associated with various visual complications.
    • Accurate diagnosis of visual impairment in diabetic patients is crucial for effective treatment.
    • Drug-induced toxicities can affect the optic nerve, leading to vision loss.

    Observation:

    • A 65-year-old woman with adult-onset diabetes developed toxic optic neuropathy.
    • The patient was undergoing treatment with chlorpropamide (Diabenese).
    • Visual acuity improved significantly after chlorpropamide therapy was discontinued.

    Findings:

    • Chlorpropamide therapy was identified as the cause of toxic optic neuropathy.
    • Discontinuation of chlorpropamide led to the resolution of optic neuropathy.

    Related Experiment Videos

  • This case highlights a specific drug-induced visual impairment in diabetics.
  • Implications:

    • Clinicians should consider drug-induced optic neuropathy in the differential diagnosis of visual loss in diabetic patients.
    • Identifying and discontinuing causative medications like chlorpropamide is essential for managing toxic optic neuropathy.
    • This underscores the need for comprehensive medication review in diabetic eye care.